Clinical Trial Update: A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluated INR101 Injection for PET/CT imaging in healthy male subjects and patients with suspected prostate cancer. The study phases were Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• INR101 Injection (INR101)

Snippet

Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd | Conditions: Healthy Male Subjects, Suspected Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED